First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2008-09-19 15:55:46Open Document File Size: 422,25 KBShare Result on FacebookCityOB / /CompanyGoldman / Marketed Unapproved Drugs CPG / Sage Pharmaceuticals / /CountryUnited States / / /EventReorganization / FDA Phase / Second Stock Issuance / /IndustryTermpapain-containing topical drug products / Topical drug products / unapproved drug product / unapproved topical papain drug products / contact lens solution / topical papain drug products / activity involving retail / notice that any product / papain drug products / topical papain products / unapproved topical drug product / papain-containing products / Drug manufacturers / topical products / manufacturing practices / unapproved topical product / topical drug product / topical product / manufacturing / unapproved topical drug products / food industry / drug products / or ships such products / /MedicalConditionanaphylactic shock / local inflammation / anaphylaxis / pressure ulcers / allergy / seizure / acute and chronic lesions / hypersensitivity / varicose ulcers / /OrganizationEnforcement Action Dates AGENCY / office of New Drugs / Food and Drug Administration / office of Compliance / Division of Dermatology and Dental Products / Division of New Drugs and Labeling Compliance / Center for Drug Evaluation and Research / DEPARTMENT OF HEALTH AND HUMAN SERVICES Display Date / /PersonSilver Spring / / /PositionGovernor / Deputy Commissioner for Policy / chief executive officer / Commissioner for Policy and Planning / /Productunapproved drug / /ProvinceOrStateSouth Carolina / Maryland / /PublishedMediumthe FDA Staff Manual Guide / /URLhttp /SocialTag |